In osteosarcoma cells, ROR2 enhances the transcriptional response to Wnt135; in lung carcinoma cells, ROR2 activates Wnt3a-induced canonical Wnt signaling as a co-receptor with Fzd231. Here, ROR2 is linked to lung carcinoma.